We are live on ! Find out more
IRD

Opus Genetics
IRD

23 hedge funds and large institutions have $10.2M invested in Opus Genetics in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

39% more capital invested

Capital invested by funds: $7.3M → $10.2M (+$2.88M)

30% less funds holding

Funds holding: 33 → 23 (-10)

56% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 18

Holders
23
Holders Change
-10
Holders Change %
-30.3%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
1
Closed
18
Calls
$86K
Puts
–
Net Calls
+$86K
Net Calls Change
+$86K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.11M
2
AFM
Anson Funds Management
Texas
+$2.12M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.29M
4
SM
Sabby Management
Florida
+$1M
5
BlackRock
BlackRock
New York
+$493K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$286K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$86K
3
BMC
Benin Management Corp
Connecticut
-$63K
4
GC
Guggenheim Capital
Illinois
-$42K
5
Citadel Advisors
Citadel Advisors
Florida
-$40K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$2.9M +$4.11M +21,163 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.4M +$1.29M +6,645 +61%
AFM
3
Anson Funds Management
Texas
$1.5M +$2.12M +10,901 New
Renaissance Technologies
4
Renaissance Technologies
New York
$1.45M -$286K -1,470 -12%
SM
5
Sabby Management
Florida
$706K +$1M +5,145 New
BlackRock
6
BlackRock
New York
$475K +$493K +2,534 +272%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$417K +$69K +355 +13%
Northern Trust
8
Northern Trust
Illinois
$137K +$70.6K +363 +57%
HVIA
9
Hudson Valley Investment Advisors
New York
$57K – – –
NFC
10
Northeast Financial Consultants
Connecticut
$43K – – –
Bank of New York Mellon
11
Bank of New York Mellon
New York
$39K +$3.69K +19 +7%
WS
12
Wedbush Securities
California
$30K +$42.6K +219 New
Morgan Stanley
13
Morgan Stanley
New York
$11K +$15K +77 New
Deutsche Bank
14
Deutsche Bank
Germany
$4K +$6.8K +35 New
Wells Fargo
15
Wells Fargo
California
$3K – – –
VCM
16
Vigilant Capital Management
Maine
$2K – – –
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$2K +$1.17K +6 +60%
LTFS
18
Ladenburg Thalmann Financial Services
Florida
$1K +$1.17K +6 +300%
WA
19
WFG Advisors
Texas
$1K +$1.94K +10 New
FDCDDQ
20
Federation des caisses Desjardins du Quebec
Quebec, Canada
$575 – – –
Acadian Asset Management
21
Acadian Asset Management
Massachusetts
– -$86K -349 Closed
BMC
22
Benin Management Corp
Connecticut
– -$63K -256 Closed
GC
23
Guggenheim Capital
Illinois
– -$42K -172 Closed
Citadel Advisors
24
Citadel Advisors
Florida
– -$40K -163 Closed
Millennium Management
25
Millennium Management
New York
– -$26K -106 Closed
1
2

IRD Hedge Fund Activity: Q2 2017 in Review

23 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2017, worth a combined $10.2M — up 39% from $7.3M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of IRD and 8 opened new positions — a net loss of 10 holders — while 1 trimmed existing stakes and 7 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $4.11M. The largest seller was Renaissance Technologies, cutting an estimated $286K.

  • 23 institutional investors held Opus Genetics (IRD) as of Q2 2017, down from 33 in Q1 2017.
  • Funds reported $10.2M of Opus Genetics stock for Q2 2017, up 39% quarter-over-quarter.
  • 8 funds opened new Opus Genetics positions in Q2 2017 and 18 closed out, a net change of -10 holders.
  • The largest Opus Genetics buyer in Q2 2017 was Susquehanna International Group, an estimated $4.11M added.
  • The largest Opus Genetics seller in Q2 2017 was Renaissance Technologies, an estimated $286K sold.

Based on aggregated 13F filings for Q2 2017.